
Chemical and Pharmaceutical Bulletin p. 996 - 1007 (1997)
Update date:2022-08-03
Topics:
Watanabe, Toshihiro
Kinoyama, Isao
Kakefuda, Akio
Okazaki, Toshio
Takizawa, Kenji
Hirano, Seiko
Shibata, Hiroshi
Yanagisawa, Isao
A series of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one derivatives containing the succinamide skeleton has been synthesized and evaluated for M1, M2 and M3 muscarinic receptor binding affinities (in vitro) and M2 and M3 muscarinic receptor antagonistic activities (in vivo). Some of them showed higher and more selective binding affinities for M2 muscarinic receptors than that of AF-DX 116. Among them, 11-[3-[N-[2-(N- benzyl-N-methylamino)ethyl]-N-ethylearbamoyl]propionyl]-5,11-dihydro-6H- pyrido[2,3-b][1,4]benzodiazepin-6-one (68) was found to be the most potent and selective M2 muscarinic receptor antagonist in vitro. This compound also strongly inhibited the oxotremorine-induced bradycardia after intravenous administration and showed 130-fold selectivity for M2 muscarinic receptors over M3 muscarinic receptors in vivo.
View MoreTIANJIN NORTH JINHENG CHEMICAL PLANT.
Contact:0086-22-59952083
Address:DongShigu Country In JiXian TianJin China
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Contact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
Nanjing Fubang Chemical Co.,Ltd
Contact:+86-25-83179199
Address:5F,Tianzheng international plaza,No399 Zhongyang Road ,Nanjing China
Tianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
Doi:10.1016/j.bmc.2004.05.027
(2004)Doi:10.1021/jo00325a013
(1981)Doi:10.1248/cpb.35.2774
(1987)Doi:10.1021/jo00342a017
(1982)Doi:10.1097/00002820-200110000-00006
()Doi:10.1246/bcsj.53.2304
(1980)